Table 2.
Outcome Measures | Pre-Post | Unmatched Treatment | Group Effect | Interaction | Time Effect (n=82 with | |
---|---|---|---|---|---|---|
Groups | (F df) | (F df) | complete data) | |||
(F df) | ||||||
Opposite | EBC | Intention to Treat* (n=96) | ||||
Mean | Mean | (F df) | ||||
(SD) | (SD) | |||||
Back pain/10 | Pre | 6.04 | 5.78 | 0.01 1,80 (p=0.98) | 1.31 1,80 (p=0.26) | 10.88 1,80 (p=0.001) |
(2.22) | (2.02) | 101.72 1,94 (p<0.001) | ||||
Post | 5.09 | 5.33 | ||||
(2.28) | (2.18) | |||||
Leg pain/10** | Pre | 3.66 | 2.75 | 0.70 1,75 (p=0.42) | 1.42 1,75 (p=0.24) | 0.02 1,75 (p=0.90) |
(3.23) | (3.04) | 0.039 1,93 (p=0.94) | ||||
Post | 3.27 | 3.11 | ||||
(2.95) | (3.21) | |||||
RMDQ: Total yes/24 | Pre | 15.61 | 19.65 | 8.36 1,78 (p<0.001) | 1.03 1,78 (p=0.31) | 2.76 1,78 (p=0.10) |
(6.16) | (4.21) | 2.70 1,94 (p=0.10) | ||||
Post | 15.09 | 17.76 | ||||
(6.75) | (5.90) | |||||
Medication: Total | Pre | 3.50 | 2.73 | 0.65 1,29 (p=0.43) | 0.12 1,29 (p=0.73) | 4.30 1,29 (p=0.047) |
pills/day** | (2.90) | (2.02) | 0.050 1,48 (p=0.82) | |||
Post | 2.56 | 2.06 | ||||
(2.76) | (1.83) | |||||
During the past week, | Pre | 3.37 | 3.34 | 0.42 1,79 (p=0.66) | 1.65 1,79 (p=0.20) | 2.17 1,79 (p=0.15) |
pain interference | (1.06) | (0.91) | 4.461 1,94 (p=0.037) | |||
with usual work, | Post | 3.13 | 3.34 | |||
in and outside | (1.09) | (0.97) | ||||
home: rating (0–5) | ||||||
BDI-11/63 | Pre | 7.31 | 6.50 | 0.70 1,74 (p=0.41) | 1.19 1,74 (p=0.28) | 13.97 1,78 (p<0.001) |
(7.24) | (6.33) | 25.10 1,94 (p<0.001) | ||||
Post | 6.31 | 4.71 | ||||
(7.16) | (4.17) | |||||
Taking medication (Yes) | Pre | 12 | 8 | McNemar test used for time effect (p=0.63) | ||
(63.2%) | (66.7%) | Groups collapsed due to small n (p=0.55) | ||||
Post | 10 | 8 | ||||
(52.6%) | (66.7%) |
Opposite = evidence-based advice and exercises opposite to direction preference; EBC = evidence-based advice and common back exercises with no directional preference; RMDQ = Roland Morris Disability Questionnaire; BDI = Beck Depression Inventory
*Intention-to-treat analysis using carry-forward of last known data point
**Floor effect: those with no leg pain/no medication at baseline were excluded from analysis.